Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Toyoshi Yanagihara, Seidai Sato, Chandak Upagupta, Martin Kolb. What have we learned from basic science studies on idiopathic pulmonary fibrosis?. Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170050; 10.1183/16000617.0050-2017 Year: 2017 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models Source: Eur Respir Rev 2014; 23:231-238 Year: 2014 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Source: Eur Respir Rev 2015; 24: 420-427 Year: 2015 Insights into idiopathic pulmonary fibrosis in the real world Source: Eur Respir J 2015; 46: 16-18 Year: 2015 Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021 Year: 2022 A recurring theme in pulmonary fibrosis genetics Source: Eur Respir J, 49 (5) 1700545; 10.1183/13993003.00545-2017 Year: 2017 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)? Source: Eur Respir J 2007; 30: Suppl. 51, 578s Year: 2007 Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017 Year: 2017